Market-leading intelligence is the catalyst behind Novacyt's ability to anticipate - and respond - to emerging new SARS-CoV-2 variants. Global tracking of virus mutations enables its R & D division to quickly develop tests that not only identify variants of concern (VOCs) - originally identified in countries such as the UK, Brazil, South Africa etc [...]The post Global bioinformatics surveillance drives innovation in SARS-CoV-2 variant detection tests appeared first on Primerdesign Real-Time PCR Blog.